Evoke Pharma Inc expected to post a loss of 8  cents a share - Earnings Preview

Evoke Pharma

05/03/2022 24:29

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a
rise
in quarterly revenue when it reports  results on March 8. 
    * The Solana Beach California-based  company is expected to
report
 a 2,102.4% increase in revenue to $507 thousand from $23.02
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Evoke Pharma Inc is
for a
loss of 8 cents per share. For the same quarter last year, the
company reported a loss of 9 cents per share.
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $9​, about 93.3% above​ its last closing price of $0.60. ​​​

This summary was machine generated March 5 at 00:29 GMT.  All
figures in US dollars  unless otherwise stated